Article: 5 Key Details As Drugmakers Face $50B Opioid Trial In Calif.

Article - Media, Publications

5 Key Details As Drugmakers Face $50B Opioid Trial In Calif.

Jeff Overley, Cara Salvatore and Emily Field, 16 April 2021

Barring last-minute settlements, Johnson & Johnson, Endo Pharmaceuticals and other major drugmakers are poised to go to trial Monday against some of California’s largest counties, which are seeking $50 billion in one of the nation’s oldest opioid-crisis cases.

The West Coast clash centers on now-familiar allegations that pharmaceutical manufacturers — divisions of J&J, Endo, Teva Pharmaceuticals and Allergan PLC — to varying degrees bankrolled pernicious promotional campaigns for prescription painkillers, unleashing a devastating wave of drug dependence and death. Continue reading “Article: 5 Key Details As Drugmakers Face $50B Opioid Trial In Calif.”